文献速递运动医学关节外科

骨髓来源富血小板纤维蛋白对兔退行性肩袖模型中肩袖愈合的有效性

Effectiveness of Bone Marrow-Derived Platelet-Rich Fibrin on Rotator Cuff Healing in a Rabbit Degenerative Model.
PubMed 文献 · Am J Sports Med · 2022-08-23

在兔退行性肩袖撕裂模型中,比较对照、富血小板血浆(PRP)、外周血来源富血小板纤维蛋白(P-PRF)和骨髓来源富血小板纤维蛋白(BM-PRF)辅助肩袖修复的效果。BM-PRF组在4周连续性显著更优且血管内皮生长因子(VEGF)阳性细胞显著多于对照组,12周改良肌腱成熟评分显著高于对照组和PRP组;P-PRF组与对照组无显著差异。

要点

  • BM-PRF组4周连续性显著优于其他组(P < .05)。
  • BM-PRF组4周VEGF阳性细胞显著多于对照组(P < .01)。
  • BM-PRF组12周改良肌腱成熟评分显著高于对照组和PRP组(P < .05)。

核心结论

  • 兔退行性肩袖撕裂模型显示,肩袖修复联合BM-PRF可增强肌腱-骨连续性、增加4周VEGF阳性细胞并在12周获得更优的肌腱-骨成熟。

研究设计与样本

  • controlled laboratory study,68只幼兔分为对照组、PRP组、P-PRF组和BM-PRF组,退行性肩袖撕裂模型在开始研究前2周建立。

主要发现

  • BM-PRF组4周连续性显著优于其他组(P < .05)。
  • BM-PRF组VEGF阳性染色细胞显著多于对照组(P < .01)。
  • BM-PRF组12周改良肌腱成熟评分显著高于对照组和PRP组(P < .05)。
  • P-PRF组改良肌腱成熟评分与对照组相比无显著差异。

临床怎么用

  • 作者指出,肩袖修复联合BM-PRF有潜力改善肩袖撕裂的临床结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platelet-rich fibrin (PRF) is a second-generation platelet concentrate. Although peripheral blood-derived PRF (P-PRF) is commonly applied in biological augmentation, there is no report about the therapeutic effect of bone marrow-derived PRF (BM-PRF) for degenerative rotator cuff tears (RCTs). PURPOSE/HYPOTHESIS: To examine the effects of platelet-rich plasma (PRP), P-PRF, and BM-PRF during rotator cuff repair (RCR) in degenerative RCTs in rabbits. We hypothesized that BM-PRF would accelerate the bone-tendon healing after RCR. STUDY DESIGN: Controlled laboratory study. METHODS: Degenerative RCT models were created 2 weeks before beginning the study, and 68 juvenile rabbits were divided into 4 groups: the control, PRP, P-PRF, and BM-PRF groups. RCR without augmentation was done in the control group. PRP was prepared by centrifuging peripheral blood twice using a plastic tube. P-PRF and BM-PRF were prepared by centrifuging peripheral blood and bone marrow, respectively, using a glass tube. Rabbits from PRP, P-PRF, and BM-PRF groups were administered the augmentation in a similar fashion for RCR, between the rotator cuff and the footprint of the humerus. At 4, 8, and 12 weeks, rabbits were euthanized and histologically assessed using hematoxylin and eosin staining, Alcian blue staining, and immunohistochemical staining for type I and III collagen. The sections were also evaluated with immunofluorescence staining of vascular endothelial growth factor (VEGF) at 4 weeks. RESULTS: The continuity was significantly better in the BM-PRF group at 4 weeks (P < .05). Immunofluorescence staining demonstrated that VEGF-positive stained cells were significantly greater in the BM-PRF group than in the control group (P < .01). The modified tendon maturing score was significantly greater in the BM-PRF group than in the control and PRP groups at 12 weeks (P < .05). There was no significant difference in the modified tendon maturing score of the P-PRF group compared with the control group. CONCLUSION: The rabbit model of degenerative RCTs demonstrated that RCR combined with BM-PRF enhanced tendon-bone continuity and increased the VEGF-positive cells at 4 weeks and obtained preferable tendon-bone maturation at 12 weeks. CLINICAL RELEVANCE: RCR augmented with BM-PRF has the potential to improve clinical outcomes for RCTs.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Uno T, Maruyama M, Satake H, et al. Effectiveness of Bone Marrow-Derived Platelet-Rich Fibrin on Rotator Cuff Healing in a Rabbit Degenerative Model. Am J Sports Med. 2022. PMID: 35998037. doi:10.1177/03635465221116084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。